Literature DB >> 17201800

Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.

Nienke Bolk1, Theo J Visser, Andries Kalsbeek, Ron T van Domburg, Arie Berghout.   

Abstract

OBJECTIVE: Standard drug information resources recommend that l-thyroxine be taken half an hour before breakfast on an empty stomach, to prevent interference of its intestinal uptake by food or medication. We observed cases in which TSH levels improved markedly after changing the administration time of l-thyroxine to the late evening. We therefore conducted a pilot-study to investigate whether l-thyroxine administration at bedtime improves TSH and thyroid hormones, and whether the circadian rhythm of TSH remains intact. DESIGN Patients were studied on two occasions: on a stable regimen of morning thyroxine administration and two months after switching to night-time thyroxine using the same dose. On each occasion patients were admitted for 24 h and serial blood samples were obtained. PATIENTS: We investigated 12 women treated with l-thyroxine because of primary hypothyroidism, who used no medication known to interfere with l-thyroxine uptake. MEASUREMENTS: Patients were admitted to hospital and blood samples were obtained at hourly intervals for 24 h via an indwelling catheter. Following this first hospital admission, all women were asked to switch the administration time from morning to bedtime or vice versa. After 2 months they were readmitted for a 24-h period of hourly blood sampling. Blood samples were analysed for serum TSH (immunometric assay), FT4 and T3 (competitive immunoassay), T4 and rT3 (radioimmunoassay), serum TBG (immunometric assay) and total protein and albumin (colourimetric methods).
RESULTS: A significant difference in TSH and thyroid hormones was found after switching to bedtime administration of l-thyroxine. Twenty-four-hour average serum values amounted to (mean +/- SD, morning vs bedtime ingestion): TSH, 5.1 +/- 0.9 vs 1.2 +/- 0.3 mU/l (P < 0.01); FT4, 16.7 +/- 1.0 vs 19.3 +/- 0.7 pmol/l (P < 0.01); T3, 1.5 +/- 0.05 vs 1.6 +/- 0.1 nmol/l (P < 0.01). There was no significant change in T4, rT3, albumin and TBG serum levels, nor in the T3/rT3 ratio. The relative amplitude and time of the nocturnal TSH surge remained intact.
CONCLUSIONS: l-thyroxine taken at bedtime by patients with primary hypothyroidism is associated with higher thyroid hormone concentrations and lower TSH concentrations compared to the same l-thyroxine dose taken in the morning. At the same time, the circadian TSH rhythm stays intact. Our findings are best explained by a better gastrointestinal uptake of l-thyroxine during the night.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17201800     DOI: 10.1111/j.1365-2265.2006.02681.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  27 in total

Review 1.  Detection and treatment of congenital hypothyroidism.

Authors:  Annette Grüters; Heiko Krude
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

2.  Levothyroxine replacement doses are affected by gender and weight, but not age.

Authors:  Madhuri Devdhar; Rebecca Drooger; Marieta Pehlivanova; Gurdeep Singh; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2011-07-13       Impact factor: 6.568

3.  Pharmacotherapy: hypothyroidism-should levothyroxine be taken at bedtime?

Authors:  Mark Vanderpump
Journal:  Nat Rev Endocrinol       Date:  2011-03-01       Impact factor: 43.330

4.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 5.  Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?

Authors:  Marco Castellana; Carlo Castellana; Luca Giovanella; Pierpaolo Trimboli
Journal:  Endocrine       Date:  2020-01-17       Impact factor: 3.633

6.  Timing of levothyroxine administration affects serum thyrotropin concentration.

Authors:  Thien-Giang Bach-Huynh; Bindu Nayak; Jennifer Loh; Steven Soldin; Jacqueline Jonklaas
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

7.  Effect of timing of levothyroxine administration on the treatment of hypothyroidism: a three-period crossover randomized study.

Authors:  Marko Skelin; Tomo Lucijanić; Ana-Marija Liberati-Čizmek; Sanja Majanović Klobučar; Marko Lucijanić; Lejsa Jakupović; Miro Bakula; Jelena Vučak Lončar; Srečko Marušić; Tomas Matić; Željko Romić; Jerka Dumić; Dario Rahelić
Journal:  Endocrine       Date:  2018-07-24       Impact factor: 3.633

Review 8.  Update on the treatment of hypothyroidism.

Authors:  Jacqueline Jonklaas
Journal:  Curr Opin Oncol       Date:  2016-01       Impact factor: 3.645

9.  Evaluation of adequacy of levo-thyroxine dosage in patients with differentiated thyroid carcinoma: correlation between morning and afternoon TSH determination.

Authors:  L Conte; E Monti; S Gay; P Marroni; A Adorno; M Mittica; M Mussap; M Giusti
Journal:  J Endocrinol Invest       Date:  2018-02-23       Impact factor: 4.256

10.  Levothyroxine Administration during Ramadan: A Prospective Randomized Controlled Trial.

Authors:  Samer El-Kaissi; Laila AbdelWareth; Ruba Dajani; Terrence J Lee-St John; Sherry Ann Santarina; Fiona Makia; Malak AlTakruri; AbedElRahman Kaskas; Yahya Ahmed
Journal:  Eur Thyroid J       Date:  2021-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.